Global Chromatography Based Cannabis Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

• In July 2022, Green Scientific Labs launched new tech for the cannabis process. The custom-designed software was built for the cannabis industry.

• In December 2022, SC Labs expanded into Southern California with a new 12,000+ square foot lab in Van Nuys, Los Angeles. The facility will provide both R&D and compliance testing for cannabis, including potency, pesticides, heavy metals, residual solvents, microbials, water activity, and more. This expansion aims to enhance testing capacity and resources for customers south of Santa Barbara.

The Global Chromatography Based Cannabis Market has been segmented by Type, Application and Geography, type into liquid chromatography, gas chromatography, and others. Liquid chromatography dominates the market due to its high accuracy, efficiency, and versatility in separating and analyzing cannabinoids, terpenes, and other compounds found in cannabis. It is extensively used in both research and regulatory testing for cannabis quality control. Gas chromatography, on the other hand, is favored for its ability to analyze volatile compounds, making it essential for assessing the potency and purity of cannabis products. The "others" segment includes techniques such as supercritical fluid chromatography (SFC), which is growing in popularity due to its ability to separate cannabinoids and terpenes with minimal solvent use.

In terms of application, the chromatography-based cannabis market is segmented into testing and analysis, quality control, product development, and research and development. Testing and analysis is the largest application segment, driven by the increasing need for accurate cannabinoid profiling, potency testing, and compliance with regulatory standards in markets where cannabis is legalized. Quality control is another key application, particularly in ensuring product consistency, purity, and safety for both medical and recreational cannabis products. Product development and research and development are growing segments, as cannabis companies invest in developing new strains, formulations, and delivery methods, with chromatography playing a critical role in analyzing and refining these innovations.

Geographically, the North American and European markets dominate the global chromatography-based cannabis market, driven by the legalization and growing acceptance of cannabis in both medicinal and recreational sectors. North America, particularly the United States and Canada, has seen a surge in demand for chromatography solutions, as regulatory requirements and safety standards are becoming more stringent. Europe is also witnessing growth, with countries like Germany and the Netherlands leading in cannabis testing and research. The Asia-Pacific region is expected to show significant growth in the coming years as cannabis research and legalization efforts expand, particularly in countries like Australia and Japan. The global demand for chromatography-based cannabis solutions is expected to rise in line with the increasing legalization, commercialization, and research efforts surrounding cannabis.

Global Chromatography Based Cannabis Segment Analysis

In this report, the Global Chromatography Based Cannabis Market has been segmented by Type, Application and Geography.

Global Chromatography Based Cannabis Market, Segmentation by Type

The Global Chromatography Based Cannabis Market is segmented by Type into Liquid Chromatography and Gas Chromatography.

Liquid Chromatography (LC) utilizes a liquid mobile phase to separate and quantify components within a sample. This method is highly versatile, offering different modes such as high-performance liquid chromatography (HPLC) and ultra-high-performance liquid chromatography (UHPLC). LC is particularly favored for its ability to handle a wide range of compounds, including polar and non-polar substances, making it essential for precise cannabinoid profiling and potency testing. It is widely employed in cannabis laboratories for its accuracy and sensitivity in quantifying THC, CBD, and other cannabinoids crucial for medical and recreational purposes.

Gas Chromatography (GC), on the other hand, employs a gaseous mobile phase to separate and analyze volatile compounds. GC is notable for its efficiency in analyzing terpenes, pesticides, and residual solvents in cannabis extracts and products. This method is particularly suited for volatile compound analysis due to its ability to achieve high resolution and sensitivity in identifying trace amounts of contaminants. GC plays a vital role in ensuring compliance with regulatory standards governing cannabis purity and safety, thereby bolstering consumer confidence in the quality of cannabis products.

The segmentation of the Global Chromatography Based Cannabis Market into Liquid Chromatography and Gas Chromatography reflects the diverse analytical needs of the cannabis industry. Each chromatographic technique contributes uniquely to quality assurance, regulatory compliance, and scientific research efforts aimed at advancing the understanding and applications of cannabis in various sectors.

Global Chromatography Based Cannabis Market, Segmentation by Application

The Global Chromatography Based Cannabis Market is segmented by Application into Pain Management, Seizures and Sclerosis.

Pain Management represents a significant segment where chromatography plays a crucial role in analyzing cannabinoids like THC and CBD, which are known for their potential pain-relieving properties. By accurately quantifying these compounds, chromatography helps ensure the consistency and efficacy of cannabis-based pain management treatments, meeting stringent regulatory requirements and enhancing patient outcomes.

Seizures and Sclerosis are two other key applications where chromatography-based analysis is pivotal. For Seizures, particularly in conditions like epilepsy, chromatography assists in determining the presence and concentration of anti-epileptic cannabinoids such as CBD, crucial for developing seizure management therapies. Similarly, in Sclerosis (referring to conditions like multiple sclerosis), chromatography aids in evaluating cannabinoids and their therapeutic effects on symptoms such as muscle spasticity and pain relief. This application underscores the role of chromatography in advancing targeted treatments that address neurological disorders through precise cannabinoid profiling.

Overall, the segmentation of the Global Chromatography Based Cannabis Market by application into Pain Management, Seizures, and Sclerosis reflects the growing recognition and adoption of chromatographic techniques in optimizing medical cannabis therapies. By facilitating accurate analysis and quality control of cannabis-derived compounds, chromatography supports the development of safe, effective treatments tailored to the specific needs of patients suffering from chronic pain, neurological conditions, and other debilitating ailments.

Global Chromatography Based Cannabis Market, Segmentation by Geography

In this report, the Global Chromatography Based Cannabis Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa and Latin America.

Global Chromatography Based Cannabis Market Share (%), by Geographical Region, 2024

The Global Chromatography Based Cannabis Market is segmented by geography to account for regional variations in regulatory frameworks, market maturity, and consumer acceptance of cannabis products. North America leads the market, driven by progressive legalization measures in countries like the United States and Canada. These regions have well-established cannabis industries, with chromatography playing a pivotal role in quality control, potency testing, and ensuring compliance with stringent regulatory standards.

Europe follows closely, with countries such as Germany, the Netherlands, and Spain emerging as key markets for medical cannabis. Chromatography is essential here for analyzing cannabinoids and terpenes in cannabis-based pharmaceuticals and ensuring product safety and consistency. The region's evolving regulatory environment, emphasizing medical cannabis research and product standardization, continues to drive the adoption of chromatography technologies.

In Asia-Pacific, markets like Australia and New Zealand are witnessing increasing legalization efforts, albeit with stricter regulatory controls compared to North America and Europe. Chromatography is crucial in these regions for precise cannabinoid profiling and monitoring of contaminants in cannabis products. However, varying cultural attitudes and regulatory complexities present both opportunities and challenges for chromatography-based cannabis testing across Asia-Pacific.

Latin America and the Middle East & Africa regions are also experiencing shifts in cannabis regulations, with countries like Uruguay and Israel pioneering medical cannabis programs. Chromatography's role in these regions is pivotal in establishing quality benchmarks and ensuring compliance with evolving regulatory requirements. As these markets mature and regulatory frameworks evolve, chromatography-based solutions are expected to play an increasingly vital role in shaping the growth and standardization of the global cannabis industry.